GCL
CELU icon

Glazer Capital LLC’s Celularity CELU Stock Holding History

Glazer Capital LLC’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-254,365
Closed -$25.6M – 952
2021
Q1 		$25.6M Buy
254,365
+186,196
+273% +$19.1M 0.37% 56
2020
Q4 		$7.5M Sell
68,169
-111,750
-62% -$11.9M 0.27% 116
2020
Q3 		$18.9M Sell
179,919
-29,914
-14% -$3.1M 0.92% 36
2020
Q2 		$21.4M Buy
209,833
+19,453
+10% +$1.93M 1.51% 22
2020
Q1 		$18.7M Buy
190,380
+180,440
+1,815% +$17.9M 1.24% 29
2019
Q4 		$989K Hold
9,940
– – 0.12% 93
2019
Q3 		$965K Buy
+9,940
New +$975K 0.12% 95

Other funds holding CELU

WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Glazer Capital LLC's CELU Position: Q2 2021 in Review

Glazer Capital LLC sold out of Celularity (CELU) in Q2 2021, closing a stake of 254,365 shares — an estimated $25.6M sold.

Glazer Capital LLC first reported a position in CELU in Q3 2019 and held it in 7 quarters. The position peaked at $25.6M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • Glazer Capital LLC reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 254,365 Celularity shares in Q2 2021, an estimated $25.6M.
  • Glazer Capital LLC first reported a position in Celularity in Q3 2019 and held it in 7 quarters.
  • Glazer Capital LLC's Celularity position peaked at $25.6M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Glazer Capital LLC's 13F filing for Q2 2021, filed 13 Aug 2021.